-+ 0.00%
-+ 0.00%
-+ 0.00%

Nuvectis Pharma Q1 EPS $(0.26) Beats $(0.32) Estimate

Benzinga·05/05/2026 11:50:37
Listen to the news
Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.32) by 18.75 percent. This is a 3.7 percent increase over losses of $(0.27) per share from the same period last year.